"The EMA is in Your Case, Now What? What You Need to Know about the EMA and How to Effectively Use Foreign Regulatory Decisions to Your Advantage," IADC's 2016 Midyear Meeting

This program highlights the major differences for prescription drug approval between the FDA and the EU's EMA. Understanding the differences are important for product liability trial lawyers because EMA risk assessments are increasingly admitted into evidence in U.S. trials.

Speaker:
Bruce Parker, Partner, Venable LLP

Visit the IADC 2016 Midyear Meeting event page for more information.